449 related articles for article (PubMed ID: 26080701)
1. Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.
Palekar RU; Jallouk AP; Lanza GM; Pan H; Wickline SA
Nanomedicine (Lond); 2015; 10(11):1817-32. PubMed ID: 26080701
[TBL] [Abstract][Full Text] [Related]
2. Small Dimension-Big Impact! Nanoparticle-Enhanced Non-Invasive and Intravascular Molecular Imaging of Atherosclerosis In Vivo.
Lenz T; Nicol P; Castellanos MI; Engel LC; Lahmann AL; Alexiou C; Joner M
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106607
[TBL] [Abstract][Full Text] [Related]
3. Emerging Magnetic Resonance Imaging Techniques for Atherosclerosis Imaging.
Wüst RCI; Calcagno C; Daal MRR; Nederveen AJ; Coolen BF; Strijkers GJ
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):841-849. PubMed ID: 30917678
[TBL] [Abstract][Full Text] [Related]
4. Emerging engineered magnetic nanoparticulate probes for targeted MRI of atherosclerotic plaque macrophages.
Kanwar RK; Chaudhary R; Tsuzuki T; Kanwar JR
Nanomedicine (Lond); 2012 May; 7(5):735-49. PubMed ID: 22630154
[TBL] [Abstract][Full Text] [Related]
5. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
[TBL] [Abstract][Full Text] [Related]
6. Hybrid, metal oxide-peptide amphiphile micelles for molecular magnetic resonance imaging of atherosclerosis.
Poon C; Gallo J; Joo J; Chang T; Bañobre-López M; Chung EJ
J Nanobiotechnology; 2018 Nov; 16(1):92. PubMed ID: 30442135
[TBL] [Abstract][Full Text] [Related]
7. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis.
Wei X; Ying M; Dehaini D; Su Y; Kroll AV; Zhou J; Gao W; Fang RH; Chien S; Zhang L
ACS Nano; 2018 Jan; 12(1):109-116. PubMed ID: 29216423
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances of Radionuclide-Based Molecular Imaging of Atherosclerosis.
Kazuma SM; Sultan D; Zhao Y; Detering L; You M; Luehmann HP; Abdalla DS; Liu Y
Curr Pharm Des; 2015; 21(36):5267-76. PubMed ID: 26369676
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in molecular imaging of atherosclerotic plaques and thrombosis.
Qiao R; Huang X; Qin Y; Li Y; Davis TP; Hagemeyer CE; Gao M
Nanoscale; 2020 Apr; 12(15):8040-8064. PubMed ID: 32239038
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance molecular imaging contrast agents and their application in atherosclerosis.
Mulder WJ; Strijkers GJ; Vucic E; Cormode DP; Nicolay K; Fayad ZA
Top Magn Reson Imaging; 2007 Oct; 18(5):409-17. PubMed ID: 18025995
[TBL] [Abstract][Full Text] [Related]
12. Molecular Cardiovascular Magnetic Resonance: Current Status and Future Prospects.
Bender YY; Pfeifer A; Ebersberger HU; Diederichs G; Hoppe P; Hamm B; Botnar RM; Makowski MR
Curr Cardiol Rep; 2016 May; 18(5):47. PubMed ID: 27038612
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic neovasculature MR imaging with mixed manganese-gadolinium nanocolloids in hyperlipidemic rabbits.
Wang K; Pan D; Schmieder AH; Senpan A; Caruthers SD; Cui G; Allen JS; Zhang H; Shen B; Lanza GM
Nanomedicine; 2015 Apr; 11(3):569-78. PubMed ID: 25652897
[TBL] [Abstract][Full Text] [Related]
14. Targeting Nanostrategies for Imaging of Atherosclerosis.
Costagliola di Polidoro A; Grassia A; De Sarno F; Bevilacqua P; Mollo V; Romano E; Di Taranto MD; Fortunato G; Bracale UM; Tramontano L; Diomaiuti TC; Torino E
Contrast Media Mol Imaging; 2021; 2021():6664471. PubMed ID: 33880112
[TBL] [Abstract][Full Text] [Related]
15. Iron oxide core oil-in-water nanoemulsion as tracer for atherosclerosis MPI and MRI imaging.
Prévot G; Kauss T; Lorenzato C; Gaubert A; Larivière M; Baillet J; Laroche-Traineau J; Jacobin-Valat MJ; Adumeau L; Mornet S; Barthélémy P; Duonor-Cérutti M; Clofent-Sanchez G; Crauste-Manciet S
Int J Pharm; 2017 Nov; 532(2):669-676. PubMed ID: 28899764
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.
Yu M; Ortega CA; Si K; Molinaro R; Schoen FJ; Leitao RFC; Xu X; Mahmoudi M; Ahn S; Liu J; Saw PE; Lee IH; Brayner MMB; Lotfi A; Shi J; Libby P; Jon S; Farokhzad OC
Theranostics; 2018; 8(21):6008-6024. PubMed ID: 30613278
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle.
Tu Y; Ma X; Chen H; Fan Y; Jiang L; Zhang R; Cheng Z
Int J Nanomedicine; 2022; 17():6773-6789. PubMed ID: 36600879
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
19. [The progress of nuclear medicine and magnetic resonance molecular imaging of atherosclerotic vulnerable plaques].
Zhao ZM; Qin SC
Sheng Li Ke Xue Jin Zhan; 2011 Apr; 42(2):86-90. PubMed ID: 21770253
[TBL] [Abstract][Full Text] [Related]
20. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
